Syntropic’s treatment for Major Depressive Disorder is a brain stimulation device based on a light stimulation protocol that was discovered by the Siegert Group at ISTA
Syntropic Medical has raised €1.1M across 3 funding rounds from 4 investors, most recently a round in Dec 2025. Based in Vienna, Austria; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-12-05 | Other | — | better ventures | View deal → |
| 2024-07-23 | Other | €1.1M | Austrian Research Promotion Agency (FFG),xista science ventures | View deal → |
| 2024-04-04 | Other | — | AWS,xista science ventures | View deal → |
